Ronald Hafner 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-24 4:57 pm Purchase | 2025-05-22 | 13D | NLS Pharmaceutics AG NLSP | Ronald Hafner | 55,713 13.200% | 24,617 (+79.17%) | Filing |
| 2024-11-21 4:01 pm Purchase | 2024-09-30 | 13G | NLS Pharmaceutics AG NLSP | Ronald Hafner | 31,096 8.100% | 31,096 (New Position) | Filing |